Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study

Clinical Breast Cancer - Tập 11 - Trang 27-32 - 2011
Daniel Rayson1, Jennifer Isabelle Payne2,3, Mohamed Abdolell2,4, Penny J. Barnes5, Rebecca F. MacIntosh5, Theresa Foley6, Tallal Younis1, Ariel Burns1, Judy Caines2,6
1Division of Medical Oncology, and Atlanta Clinical Cancer Research Unit, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia Canada
2Department of Diagnostic Radiology, Dalhousie University, Halifax, Nova Scotia, Canada
3Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
4Dalla Lana School of Public Health, University of Toronto, Ontario, Canada
5Division of Anatomic Pathology, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
6Nova Scotia Breast Screening Program, Halifax, Nova Scotia, Canada

Tài liệu tham khảo

Gotzsche, 2006, Screening for breast cancer with mammography. (review), Cochrane Database Syst Rev, CD001877

Smith, 2003, American Cancer Society guidelines for breast cancer screening: update 2003, CA Cancer J Clin, 54, 141, 10.3322/canjclin.53.3.141

Shapiro, 1998, Breast cancer screening programmes in 22 countries: current policies, administration and guidelines, Int J Epidemiol, 27, 735, 10.1093/ije/27.5.735

Rosenberg, 2006, Performance benchmarks for screening mammography, Radiology, 241, 55, 10.1148/radiol.2411051504

Perry, 2008, European guidelines for quality assurance in breast cancer screening and diagnosis, Ann Oncol, 19, 614, 10.1093/annonc/mdm481

Organized breast screening programs in Canada: report on program performance in 2003 and 2004. Public Health Agency of Canada, Ottawa, Ont. Last modified, 7/1, 2008.

Bulliard, 2006, Methodological issues in international comparison of interval breast cancers, Int J Cancer, 119, 1158, 10.1002/ijc.21941

Houssami, 2006, Radiological surveillance of interval breast cancers in screening programmes, Lancet Oncol, 7, 259, 10.1016/S1470-2045(06)70617-9

Duffy, 2008, Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival, Am J Epidemiol, 168, 98, 10.1093/aje/kwn120

Lawrence, 2009, Population estimates of survival in women with screen- detected and symptomatic breast cancer taking account of lead time and length bias, Breast Cancer Res Treat, 16, 179, 10.1007/s10549-008-0100-8

Collett, 2005, A basal epithelial phenotype is more frequent in interval breast cancers compared with screen-detected tumors, Cancer Epidemiol Biomarkers Prev, 14, 1108, 10.1158/1055-9965.EPI-04-0394

Dent, 2007, Triple-negative breast cancer: clinical features and patterns of recurrence, Clin Cancer Res, 13, 4429, 10.1158/1078-0432.CCR-06-3045

Gilliland, 2000, Biologic characteristics of interval and screen-detected breast cancers, J Natl Cancer Inst, 92, 743, 10.1093/jnci/92.9.743

Hofvind, 2008, Mammographic features and histopathological findings of interval breast cancers, Acta Radiol, 49, 975, 10.1080/02841850802403730

Collins, 1998, Survival rates from interval cancer in NHS breast screening programme, BMJ, 316, 832, 10.1136/bmj.316.7134.832

Vitak, 1997, Interval cancers and cancers in non-attenders in the Ostergotland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence, Eur J Cancer, 33, 1453, 10.1016/S0959-8049(97)00185-8

Burrell, 1996, Screening interval breast cancers: mammographic features and prognostic factors, Radiology, 199, 811, 10.1148/radiology.199.3.8638010

Wang, 2001, Interval cancers in the Norwegian breast screening program: frequency, characteristics and use of HRT, Int J Cancer, 94, 594, 10.1002/ijc.1511

Raja, 2001, Interval breast cancer: is it a different type of breast cancer?, Breast, 10, 100, 10.1054/brst.2000.0217

Zackrisson, 2007, Improved survival rate for women with interval breast cancer- results from the breast screening programme in malmo, Sweden 1976-1999, J Med Screen, 14, 138, 10.1258/096914107782066239

Brekelmans, 1995, Survival in interval breast cancer in the DOM screening programme, Eur J Cancer, 31A, 1830, 10.1016/0959-8049(95)00324-C

Porter, 1999, Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers, J Natl Cancer Inst, 91, 2020, 10.1093/jnci/91.23.2020

Bordas, 2007, Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden, Breast, 16, 47, 10.1016/j.breast.2006.05.006

Porter, 2006, Interval breast cancers: prognostic features and survival by subtype and time since screening, J Med Screen, 13, 115, 10.1258/096914106778440572

Bare, 2006, Relationship between the method of detection and prognostic factors for breast cancer in a community with a screening programme, J Med Screen, 13, 183, 10.1177/096914130601300405

Nova Scotia Breast Screening Program Annual Report 2008 (2007 data). Nova Scotia Health, Halifax NS, 2008.

Hofvind, 2005, Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program, Radiology, 237, 437, 10.1148/radiol.2372041174

Ciatto, 2007, Interval breast cancers in screening: the effect of mammography review method on classification, Breast, 16, 646, 10.1016/j.breast.2007.05.010

Caines JS, Gallant J, Foley T, Payne JI. A review of interval breast cancers diagnosed among participants of a Canadian breast screening program (in preparation).

Wolff, 2007, American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, 25, 118, 10.1200/JCO.2006.09.2775

Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056/NEJMoa050518

Cronin, 2006, Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis, J Natl Cancer Inst Monogr, 36, 112, 10.1093/jncimonographs/lgj015

Boyd, 2007, Mammographic density and the risk and detection of breast cancer, N Engl J Med, 356, 227, 10.1056/NEJMoa062790

Buist, 2004, Factors contributing to mammography failure in women aged 40-49 years, J Natl Cancer Inst, 96, 1432, 10.1093/jnci/djh269

Thông tin
Thông tin xuất bản

Clinical Breast Cancer

Tập 11

27-32

Thông tin tác giả